148 related articles for article (PubMed ID: 2488182)
1. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
Halstenson CE; Blevins RB; Salem NG; Matzke GR
Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
5. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
[TBL] [Abstract][Full Text] [Related]
6. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.
Ferrazzini G; Klein J; Sulh H; Chung D; Griesbrecht E; Koren G
J Pediatr; 1990 Nov; 117(5):823-6. PubMed ID: 2231218
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after oral single- and multiple-dose administration to healthy pigs.
Mengelers MJ; van Gogh ER; Huveneers MB; Hougee PE; Kuiper HA; Pijpers A; Verheijden JH; van Miert AS
Vet Res Commun; 2001 Aug; 25(6):461-81. PubMed ID: 11519678
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
Nissenson AR; Wilson C; Holazo A
Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
Martea M; Hekster YA; Vree TB; Voets AJ; Berden JH
Pharm Weekbl Sci; 1987 Apr; 9(2):110-6. PubMed ID: 3495778
[TBL] [Abstract][Full Text] [Related]
15. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
[TBL] [Abstract][Full Text] [Related]
16. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
[TBL] [Abstract][Full Text] [Related]
17. Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: risk of under-dosing using current dosing recommendations.
Clajus C; Kühn-Velten WN; Schmidt JJ; Lorenzen JM; Pietsch D; Beutel G; Kielstein JT
BMC Pharmacol Toxicol; 2013 Apr; 14():19. PubMed ID: 23551893
[TBL] [Abstract][Full Text] [Related]
18. Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.
Smeltzer BD; Schwartzman MS; Bertino JS
Antimicrob Agents Chemother; 1988 Feb; 32(2):236-40. PubMed ID: 3364945
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose kinetics of ofloxacin in patients on continuous ambulatory peritoneal dialysis (CAPD).
Passlick J; Wonner R; Keller E; Essers L; Grabensee B
Perit Dial Int; 1989; 9(4):267-72. PubMed ID: 2488379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
